Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Neoplasms 2Platelet Glycoprotein IV Deficiency 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Cyst 1Neoplasm Metastasis 1Fatty Liver 1Disease 1Cysts 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 38pembrolizumab 36Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 18Exercise 17Carboplatin 16Nivolumab 15atezolizumab 14Cisplatin 14Drug Therapy 13Paclitaxel 12Fluorouracil 12Cyclophosphamide 12Cetuximab 12Trastuzumab 10Leucovorin 10Docetaxel 10Dexamethasone 10Pemetrexed 9Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × Endosonography × Clear all
NCT06831136 2025-09-10

PANCARDINAL-2

The University of Texas Health Science Center, Houston

Phase 2 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06867172 2025-03-10

SPACE

Carol Davila University of Medicine and Pharmacy

Recruiting
66 enrolled
Gastrointestinal

Platelet Glycoprotein IV Deficiency, Adenocarcinoma, Cysts, Fatty Liver, Neoplasms, Pancreatic Cyst

Data powered by HemOnc (CC BY 4.0) Colophon âš¡